Sigma Live

Middle East Conflict Disrupts Drug Supply to Gulf Countries

Published March 16, 2026, 10:10
Middle East Conflict Disrupts Drug Supply to Gulf Countries

The conflict in the Middle East is disrupting the supply chains of vital medicines to Gulf countries, putting access to critical drugs, including cancer treatments and those requiring refrigeration, at risk. Companies are being forced to reroute flights and seek land routes to deliver medications. The conflict has closed significant air and sea transport hubs, impacting the delivery of medicines, food, and oil. While there are currently no major shortages, the situation could worsen if the war continues. Gulf countries are heavily reliant on drug imports, and some medicines have a limited shelf life and require refrigeration, making land transport less practical. Pharmaceutical companies are seeking alternative routes, such as through Saudi Arabia, Turkey, or Oman. The airports of Dubai, Abu Dhabi, and Doha have closed due to Iranian attacks, significantly disrupting transport. The disruption of these hubs is impacting the global supply chain, with over one-fifth of global air freight affected. Alternative cold chain routes are difficult to establish quickly and are not always available.